Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

THBS1 (thrombospondin-1)

Identity

Other namesTSP1
platelet glycoprotein G
Hugo THBS1
Location 15q15
Local_order Telomeric to FLJ39531, centromeric to FSIP1 (fibrous sheath interacting protein 1)

DNA/RNA

 
  Intron-exon organization of the THBS1 gene.
Description The THBS1 gene is 16,393 bases in size and is composed of 22 exons. Exons 2-21 encode the 5729 b mRNA.
Transcription Egr-1 and Sp1 sites function in the constitutive transcription of THBS1 stimulated by serum. Transcription is regulated by c-Jun/AP-1 in cooperation with the repressor Yin Yang-1 (YY-1) and by p53. USF2 mediates glucose-induced TSP1 transcription. Id1 represses transcription. The ATF-1 transcription factor also down-regulates transcription of TSP1 through an ATF/cAMP-responsive element-binding protein binding site. In contrast, Myc increases turnover of thrombospondin-1 mRNA. Transcription of THBS1 in some human cancers is suppressed through hypermethylation.
Pseudogene none described

Protein

 
  Domain organization and localization of selected ligand binding sites in TSP1. TSP1 is a homotrimer linked via disulfide bonds.
Description The TSP1 precursor contains 1170 amino acids; 129,412 Da. The mature secreted protein comprises residues 19-1170 and assembles into a disulfide linked homotrimer. Secreted TSP1 is a glycoprotein with a molecular mass of 150-180 kDa that contains approximately 12 Asn-linked mono-, bi- tri-, and tetraantennary complex oligosaccharides and variable numbers of C-mannosylated Trp residues in the type 1 repeats.
Expression TSP1 is expressed in many tissues during embryonic development but has limited expression in the healthy adult. TSP1 is the most abundant protein in alpha granules of platelets, but normal plasma levels are very low (typically 100-200 ng/ml). Expression in other cell types is induced by wounding, during tissue remodeling, in atherosclerotic lesions, rheumatoid synovium, glomerulonephritis, and in stroma of many tumors. Conversely, most but not all malignant cells in tumors exhibit loss of TSP1 expression during malignant progression. This loss is due to diminished positive regulation of the THBS1 gene by suppressor genes such as p53 and NM23 and increased negative regulation by oncogenes including Ras and Myc. TSP1 expression is induced by TGF-beta, vitamin A, progesterone, and retinoids and suppressed by nickel, Id1, and hepatocyte growth factor. TSP1 expression in the epidermis of skin is suppressed following exposure to UV irradiation.
Localisation TSP1 is secreted and present transiently in extracellular matrix but is rapidly internalized for degradation by fibroblasts and endothelial cells. TSP1 is abundant in megakaryocytes and platelets and is constitutively expressed at the dermal-epidermal boundary in skin and in subendothelial matrix of some blood vessels.
Function TSP1 binds to extracellular matrix ligands including fibrinogen, fibronectin, some collagens, latent and active transforming growth factor-beta-1, TSG6, heparin, plasmin, cathepsin G, neutrophil elastase, some MMPs, tissue factor pathway inhibitor, and heparan sulfate proteoglycans. TSP1 binds to cell surface receptors including CD36, CD47, some syndecans, LDL receptor-related protein-1 (via calreticulin) and the integrins alpha-V/beta-3, alpha-3/beta-1, alpha-4/beta-1, and alpha-6/beta-1. TSP1 is a slow tight inhibitor of plasmin, cathepsin G, and neutrophil elastase. TSP1 directly binds and activates latent TGF-beta-1.
TSP1 in a context-dependent and cell-specific manner stimulates or inhibits cell adhesion, proliferation, motility, and survival. TSP1 is a potent inhibitor of angiogenesis, but N-terminal proteolytic and recombinant parts of TSP1 have clear pro-angiogenic activities mediated by beta-1 integrins. In the immune system, TSP1 is a potent inhibitor of T cell and dendritic cell activation and mediates clearance of apoptotic cells by phagocytes. In the CNS, TSP1 secreted by astrocytes promotes synaptogenesis.
Based on studies of TSP1 null mice, platelet TSP1 is not essential for platelet aggregation, but TSP1 null mice have impaired wound repair, increased retinal angiogenesis, and are hyper-responsive to several inflammatory stimuli.
Homology TSP1 is a member of the thrombospondin family that also contains thrombospondin-2, -3, -4, and cartilage oligomeric matrix protein (COMP). The central type 1 repeats are also known as thrombospondin-repeats and are shared with the larger thrombospondin/properdin repeat superfamily.

Mutations

Germinal
  • a2210g (Asn700Ser) premature familial myocardial infarction; alters Ca-binding to TSP1.
  • g1678a (Thr523Ser) genetic risk factor of cerebral thrombosis in a Chinese population.
  • Implicated in

    Entity various cancers
    Disease associated with local invasive behavior, tumor neovascularization, and metastasis.
    Prognosis Decreased TSP1 expression has been correlated with malignant progression and decreased survival in several cancers. To date, the strongest data is for colorectal carcinomas. Five independent studies involving more than 400 patients have shown significant association of reduced TSP1 expression with increased invasion, microvascular densities, and poor prognosis.
    More limited studies have shown associations of decreased TSP1 with poor prognosis in squamous non-small cell lung carcinoma, pancreatic adenocarcinoma, invasive cervical carcinoma, and oral squamous cell carcinomas.
    TSP1 is generally not a useful prognostic factor in breast or prostate cancers, although one study of 58 breast DCIS showed loss of stromal TSP1 in DCIS with more aggressive histological features. Recent evidence indicates that the failure of TSP1 to protect in most breast cancers is due to an escape mechanism involving increased VEGF expression. Finally, TSP1 was positively correlated with invasion in hepatocellular and ovarian carcinomas.
    Oncogenesis Mutation of THBS1 has not been reported in cancers, but loss of THBS1 expression due to hypermethylation, transcriptional regulation by oncogenes or tumor suppressor genes, or altered mRNA stability has been reported in many cancers. Transgenic mouse models support the tumor suppressor activity of THBS1. Mice lacking TSP1 develop tumors earlier in a p53 null background. Conversely, transgenic mice overexpressing TSP1 in skin or mammary tissue are resistant to chemical or oncogene-driven carcinogenesis.
      

    External links

    Nomenclature
    HugoTHBS1
    GDBTHBS1
    Entrez_GeneTHBS1  7057  thrombospondin 1
    Cards
    AtlasTHBS1ID42548ch15q15
    GeneCardsTHBS1
    EnsemblTHBS1 [Search_View]   ENSG00000137801 [Gene_View]
    GenatlasTHBS1
    GeneLynxTHBS1
    eGenomeTHBS1
    euGene7057
    Genomic and cartography
    GoldenPathTHBS1  -  15q15   chr15:37660572-37676959 +  15q15    (hg18-Mar_2006)
    EnsemblTHBS1 - 15q15 [CytoView]
    NCBIMapview
    OMIMDisease map [OMIM]
    HomoloGeneTHBS1
    Gene and transcription
    GenbankAB209912 [ ENTREZ ]
    GenbankAI290070 [ ENTREZ ]
    GenbankAK291639 [ ENTREZ ]
    GenbankAU117102 [ ENTREZ ]
    GenbankAU279999 [ ENTREZ ]
    RefSeqNM_003246 [ SRS ]    NM_003246 [ ENTREZ ]
    RefSeqAC_000058 [ SRS ]    AC_000058 [ ENTREZ ]
    RefSeqNC_000015 [ SRS ]    NC_000015 [ ENTREZ ]
    RefSeqNT_010194 [ SRS ]    NT_010194 [ ENTREZ ]
    RefSeqNW_925840 [ SRS ]    NW_925840 [ ENTREZ ]
    AceViewTHBS1 AceView - NCBI
    UnigeneHs.164226 [ SRS ]    Hs.164226 [ NCBI ]     HS164226 [ spliceNest ]
    Fast-db1969 (alternative variants)
    Protein : pattern, domain, 3D structure
    SwissProtP07996 [ SRS]    P07996 [ EXPASY ]     P07996 [ INTERPRO ]
    PrositePS00022 EGF_1 [ SRS ]    PS00022 EGF_1 [ Expasy ]
    PrositePS01186 EGF_2 [ SRS ]    PS01186 EGF_2 [ Expasy ]
    PrositePS50026 EGF_3 [ SRS ]    PS50026 EGF_3 [ Expasy ]
    PrositePS50092 TSP1 [ SRS ]    PS50092 TSP1 [ Expasy ]
    PrositePS51234 TSP3 [ SRS ]    PS51234 TSP3 [ Expasy ]
    PrositePS51236 TSP_CTER [ SRS ]    PS51236 TSP_CTER [ Expasy ]
    PrositePS01208 VWFC_1 [ SRS ]    PS01208 VWFC_1 [ Expasy ]
    PrositePS50184 VWFC_2 [ SRS ]    PS50184 VWFC_2 [ Expasy ]
    InterproIPR013320 ConA_like_subgrp [ SRS ]    IPR013320 ConA_like_subgrp [ EBI ]
    InterproIPR006210 EGF [ SRS ]    IPR006210 EGF [ EBI ]
    InterproIPR000742 EGF_3 [ SRS ]    IPR000742 EGF_3 [ EBI ]
    InterproIPR006209 EGF_like [ SRS ]    IPR006209 EGF_like [ EBI ]
    InterproIPR013032 EGF_like_reg_CS [ SRS ]    IPR013032 EGF_like_reg_CS [ EBI ]
    InterproIPR003129 Laminin_G_TSP_N [ SRS ]    IPR003129 Laminin_G_TSP_N [ EBI ]
    InterproIPR003367 Thrombospondin_3 [ SRS ]    IPR003367 Thrombospondin_3 [ EBI ]
    InterproIPR000884 TSP1 [ SRS ]    IPR000884 TSP1 [ EBI ]
    InterproIPR008085 TSP_1 [ SRS ]    IPR008085 TSP_1 [ EBI ]
    InterproIPR008859 TSP_C [ SRS ]    IPR008859 TSP_C [ EBI ]
    InterproIPR001007 VWF_C [ SRS ]    IPR001007 VWF_C [ EBI ]
    CluSTrP07996
    PfamPF00008 EGF [ SRS ]    PF00008 EGF [ Sanger ]    pfam00008 [ NCBI-CDD ]
    PfamPF00090 TSP_1 [ SRS ]    PF00090 TSP_1 [ Sanger ]    pfam00090 [ NCBI-CDD ]
    PfamPF02412 TSP_3 [ SRS ]    PF02412 TSP_3 [ Sanger ]    pfam02412 [ NCBI-CDD ]
    PfamPF05735 TSP_C [ SRS ]    PF05735 TSP_C [ Sanger ]    pfam05735 [ NCBI-CDD ]
    PfamPF00093 VWC [ SRS ]    PF00093 VWC [ Sanger ]    pfam00093 [ NCBI-CDD ]
    SmartSM00181 EGF [EMBL]
    SmartSM00209 TSP1 [EMBL]
    SmartSM00210 TSPN [EMBL]
    SmartSM00214 VWC [EMBL]
    BlocksP07996
    PDB1LSL [ SRS ]    1LSL [ PdbSum ],   1LSL [ IMB ]   1LSL [ RSDB ]
    PDB1UX6 [ SRS ]    1UX6 [ PdbSum ],   1UX6 [ IMB ]   1UX6 [ RSDB ]
    PDB1Z78 [ SRS ]    1Z78 [ PdbSum ],   1Z78 [ IMB ]   1Z78 [ RSDB ]
    PDB1ZA4 [ SRS ]    1ZA4 [ PdbSum ],   1ZA4 [ IMB ]   1ZA4 [ RSDB ]
    PDB2ERF [ SRS ]    2ERF [ PdbSum ],   2ERF [ IMB ]   2ERF [ RSDB ]
    PDB2ES3 [ SRS ]    2ES3 [ PdbSum ],   2ES3 [ IMB ]   2ES3 [ RSDB ]
    HPRD01765
    Protein Interaction databases
    DIPP07996
    IntActP07996
    Polymorphism : SNP, mutations, diseases
    OMIM188060    [ map ]   
    GENECLINICS188060
    SNPTHBS1 [dbSNP-NCBI]  
    SNPNM_003246 [SNP-NCI]  
    SNPTHBS1 [GeneSNPs - Utah]  THBS1] [HGBASE - SRS]
    HAPMAPTHBS1 [HAPMAP]  
    COSMICTHBS1 [Somatic mutation (COSMIC-CGP-Sanger)]  
    HGMDTHBS1
    General knowledge
    Family BrowserTHBS1 [UCSC Family Browser]
    SOURCENM_003246
    SMDHs.164226
    SAGEHs.164226
    GOendopeptidase inhibitor activity [Amigo]  endopeptidase inhibitor activity
    GOsignal transducer activity [Amigo]  signal transducer activity
    GOstructural molecule activity [Amigo]  structural molecule activity
    GOcalcium ion binding [Amigo]  calcium ion binding
    GOprotein binding [Amigo]  protein binding
    GOextracellular region [Amigo]  extracellular region
    GOextracellular region [Amigo]  extracellular region
    GOcell motility [Amigo]  cell motility
    GOcell adhesion [Amigo]  cell adhesion
    GOmulticellular organismal development [Amigo]  multicellular organismal development
    GOnervous system development [Amigo]  nervous system development
    GOblood coagulation [Amigo]  blood coagulation
    GOheparin binding [Amigo]  heparin binding
    BIOCARTATSP-1 Induced Apoptosis in Microvascular Endothelial Cell    [Genes]
    KEGGCell Communication
    KEGGTGF-beta signaling pathway
    KEGGFocal adhesion
    KEGGECM-receptor interaction
    PubGeneTHBS1
    TreeFamTHBS1
    Other databases
    Probes
    ProbeTHBS1 Related clones (RZPD - Berlin)
    PubMed
    PubMed159 Pubmed reference(s) in LocusLink

    Bibliography

    Structure and chromosomal localization of the human thrombospondin gene.
    Wolf FW, Eddy RL, Shows TB, Dixit VM
    Genomics. 1990 ; 6 (4) : 685-691.
    PMID 2341158
     
    Coronary artery disease and the thrombospondin single nucleotide polymorphisms.
    Stenina OI, Byzova TV, Adams JC, McCarthy JJ, Topol EJ, Plow EF
    The international journal of biochemistry & cell biology. 2004 ; 36 (6) : 1013-1030.
    PMID 15094117
     
    [Correlation of thrombospondin-1 G1678A polymorphism to stroke: a study in Chinese population]
    Liu XN, Song L, Wang DW, Liao YH, Ma AQ, Zhu ZM, Zhao BR, Zhao JZ, Hui RT
    Zhonghua yi xue za zhi. 2004 ; 84 (23) : 1959-1962.
    PMID 15730804
     
    Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer.
    Maeda K, Nishiguchi Y, Kang SM, Yashiro M, Onoda N, Sawada T, Ishikawa T, Hirakawa K
    Oncology reports. 2001 ; 8 (4) : 763-766.
    PMID 11410779
     
    Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.
    Rice AJ, Steward MA, Quinn CM
    Journal of clinical pathology. 2002 ; 55 (12) : 921-925.
    PMID 12461058
     
    Expression and role of thrombospondin-1 in colorectal cancer.
    Miyanaga K, Kato Y, Nakamura T, Matsumura M, Amaya H, Horiuchi T, Chiba Y, Tanaka K
    Anticancer research. 2002 ; 22 (6C) : 3941-3948.
    PMID 12553016
     
    Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo.
    Fontana A, Filleur S, Guglielmi J, Frappart L, Bruno-Bossio G, Boissier S, Cabon F, Clˆ©zardin P
    International journal of cancer. Journal international du cancer. 2005 ; 116 (5) : 686-691.
    PMID 15838828
     
    Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma.
    Poon RT, Chung KK, Cheung ST, Lau CP, Tong SW, Leung KL, Yu WC, Tuszynski GP, Fan ST
    Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 ; 10 (12 Pt 1) : 4150-4157.
    PMID 15217952
     
    Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancers.
    Linderholm B, Karlsson E, Klaar S, Lindahl T, Borg AL, Elmberger G, Bergh J
    European journal of cancer (Oxford, England : 1990). 2004 ; 40 (16) : 2417-2423.
    PMID 15519514
     
    Methylation and silencing of the Thrombospondin-1 promoter in human cancer.
    Li Q, Ahuja N, Burger PC, Issa JP
    Oncogene. 1999 ; 18 (21) : 3284-3289.
    PMID 10359534
     
    Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1.
    Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, Morris C, Shiflett CB, Devlin MK, Conant K, Alani RM
    Cancer cell. 2002 ; 2 (6) : 473-483.
    PMID 12498716
     
    Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma.
    Yang QW, Liu S, Tian Y, Salwen HR, Chlenski A, Weinstein J, Cohn SL
    Cancer research. 2003 ; 63 (19) : 6299-6310.
    PMID 14559817
     
    Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice.
    Lawler J, Miao WM, Duquette M, Bouck N, Bronson RT, Hynes RO
    The American journal of pathology. 2001 ; 159 (5) : 1949-1956.
    PMID 11696456
     
    Novel integrin antagonists derived from thrombospondins.
    Calzada MJ, Roberts DD
    Current pharmaceutical design. 2005 ; 11 (7) : 849-866.
    PMID 15777239
     
    Functional regulation of T lymphocytes by modulatory extracellular matrix proteins.
    Kuznetsova SA, Roberts DD
    The international journal of biochemistry & cell biology. 2004 ; 36 (6) : 1126-1134.
    PMID 15094127
     
    REVIEW articlesautomatic search in PubMed
    Last year publicationsautomatic search in PubMed

    Search in all EBI   NCBI

    Contributor(s)

    Written05-2005David D Roberts
    Biochemical Pathology Section, Laboratory of Pathology, CCR, NCI, Bethesda, Maryland 20892, USA

    Citation

    This paper should be referenced as such :
    Roberts DD . THBS1 (thrombospondin-1). Atlas Genet Cytogenet Oncol Haematol. May 2005 .
    URL : http://AtlasGeneticsOncology.org/Genes/THBS1ID42548ch15q15.html

    © Atlas of Genetics and Cytogenetics in Oncology and Haematology
    indexed on : Mon May 12 18:09:53 2008


    Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

    For comments and suggestions or contributions, please contact us

    j.l.huret@chu-poitiers.fr.